Sterling Investment Counsel, LLC

Position in LLY — ELI LILLY & Co

CIK 1925853 Buffalo, NY

Position in LLY

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$2,791,073

+$670,084 QoQ

Shares Held

2,327

+0.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.67%

of 13F equity value

Holder Rank

#2,194

of 4,605 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

Sterling Investment Counsel, LLC holds $9,362,958 across 6 Drug Manufacturers - General names. LLY ranks #1 (29.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,327	$2,791,073
2	ABBV	AbbVie Inc.	9,241	$2,325,405
3	MRK	Merck & Co., Inc.	13,344	$1,714,704
4	GILD	Gilead Sciences, Inc.	9,013	$1,138,702
5	JNJ	Johnson & Johnson	4,172	$1,059,562
6	AMGN	Amgen Inc	921	$333,512

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,791,073	2,327	+0.9%	Shares	Sole	2026-07-20
2026-03-31	$2,120,989	2,306	+0.8%	Shares	Sole	2026-04-16
2025-12-31	$2,457,793	2,287	+3.4%	Shares	Sole	2026-01-27
2025-09-30	$1,687,756	2,212	+427.9%	Shares	Sole	2025-10-21
2025-06-30	$326,623	419	-79.6%	Shares	Sole	2025-07-21
2025-03-31	$1,693,940	2,051	+43.0%	Shares	Sole	2025-04-21
2024-09-30	$1,270,437	1,434	+24.7%	Shares	Sole	2024-10-22
2024-06-30	$1,041,187	1,150	-0.2%	Shares	Sole	2024-07-25
2024-03-31	$896,209	1,152	+0.2%	Shares	Sole	2024-04-26
2023-12-31	$670,358	1,150	0.0%	Shares	Sole	2024-01-12
2023-09-30	$617,699	1,150	0.0%	Shares	Sole	2023-10-19
2023-06-30	$539,327	1,150	0.0%	Shares	Sole	2023-07-17
2023-03-31	$394,933	1,150	0.0%	Shares	Sole	2023-04-18
2022-12-31	$420,716	1,150	-3.6%	Shares	Sole	2023-01-20
2022-09-30	$385,756	1,193	0.0%	Shares	Sole	2022-10-21
2022-06-30	$386,806	1,193	0.0%	Shares	Sole	2022-10-20
2022-03-31	$341,639	1,193	-0.3%	Shares	Sole	2022-05-10
2021-12-31	$330,635	1,197	—	Shares	Sole	2022-04-29
No filing history on record for this holder in this stock.